Management of New Hepatitis B Diagnosis with Alcohol Use History

Immediate Alcohol Cessation

Patients with newly diagnosed Hepatitis B who consume alcohol must immediately stop all alcohol intake and be referred to a hepatitis B specialist for comprehensive evaluation and consideration of antiviral therapy, as recommended by the Centers for Disease Control and Prevention (CDC) 1, 2
Complete abstinence from alcohol is non-negotiable for patients with chronic HBV infection, as alcohol consumption accelerates liver damage, increases progression to cirrhosis and hepatocellular carcinoma, and worsens mortality even in patients receiving antiviral therapy, according to the CDC 1, 2
Refer patients needing evaluation or treatment for alcohol abuse to appropriate services immediately, as advised by the CDC 1, 2

All patients with chronic HBV infection should be evaluated by or in consultation with a physician experienced in managing chronic liver disease, because 15-25% are at risk for premature death from cirrhosis and liver cancer, as recommended by the CDC 1, 2, 5, 6
The initial evaluation must include a complete blood count and comprehensive liver panel, HBV replication markers, coinfection screening, hepatitis A antibody, and baseline alpha-fetoprotein, as recommended by the CDC 1, 2, 5, 6

Administer hepatitis A vaccine if chronic liver disease is present or if the patient lacks HAV antibody, as recommended by the CDC 1, 2, 5, 6
Superimposed hepatitis A infection in persons with chronic liver disease has been associated with fulminant hepatitis, according to the American Association for the Study of Liver Diseases 7

Antiviral therapy decisions depend on HBV DNA levels, ALT elevation, and degree of liver fibrosis, which must be assessed by the hepatitis B specialist, as recommended by the CDC 1, 2
Seven FDA-approved therapies exist for chronic HBV, including nucleos(t)ide analogues like entecavir, as approved by the FDA 1

All patients with chronic HBV require lifelong monitoring to assess disease progression, hepatocellular carcinoma development, treatment need, and treatment response, as recommended by the CDC 1, 2, 6
Patients at high risk for HCC require ultrasound and AFP screening every 6 months, as recommended by the CDC 2, 5, 6

Patients must be counseled to notify household, sexual, and needle-sharing contacts for HBV testing and vaccination, use condoms with non-immune sexual partners, and never donate blood, plasma, tissue, or semen, as recommended by the CDC 2, 5, 6